NAPLEX (North American Pharmacist Licensure Examination) Practice Exam 2026 - Free NAPLEX Practice Questions and Study Guide

Triumeq is a first line treatment for HIV that contains a combination of three drugs dolutegravir, an integrase inhibitor; abacavir, a nucleoside reverse transcriptase inhibitor; and lamivudine, another nucleoside reverse transcriptase inhibitor. Option A is the only choice that includes all three of these medications. Option B contains four drugs, including Tenofovir Alafenamide (TAF), which is not one of the ingredients in Triumeq. Option C contains Efavirenz, a non-nucleoside reverse transcriptase inhibitor, and Tenofovir Disoproxil Fumarate (TDF), which is also not included in Triumeq. Option D only has two of the three required medications (dolutegravir and lamivudine), making it an incomplete answer. Therefore, option A is the correct choice as it contains all three components of Triumeq, making it a true first line treatment option.